))
PRRT (Part Three) with NET Patient Advocate, Josh Mailman
Manage episode 349899330 series 3426844
Content provided by Learn Advocate Connect Neuroendocrine Tumor Society. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Learn Advocate Connect Neuroendocrine Tumor Society or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
How can patients make decisions about where, when, and what kind of PRRT to receive? How does PRRT in the USA differ from other parts of the world? Why does each institution have different post-PRRT radiation safety precautions? What is the patient experience with traveling after PRRT? Internationally recognized patient advocate and President of NorCal CarciNET Community, Josh Mailman, answers ten common questions about the past, present, and future of PRRT. Josh, whose journey has taken him from PRRT recipient to a seat on the Nuclear Regulatory Commission Advisory Committee, shares from his years of patient advocacy work in nuclear medicine and clarifies some misunderstandings about PRRT. Listen now!
For more information, visit LACNETS.org.
36 episoade
Distribuie
